Is Oncodesign Precision Medicine Opm SA halal to invest in?

According to Musaffa's Shariah screening methodology, Oncodesign Precision Medicine Opm SA (ALOPM.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Oncodesign Precision Medicine Opm SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Oncodesign Precision Medicine Opm SA using these criteria to determine its compliance status.

Can Muslims buy shares of Oncodesign Precision Medicine Opm SA?

Muslim investors may consider investing in Oncodesign Precision Medicine Opm SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Oncodesign Precision Medicine Opm SA classified as NOT HALAL?

Musaffa determines the Shariah status of Oncodesign Precision Medicine Opm SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Oncodesign Precision Medicine Opm SA updated?

The Shariah compliance status of Oncodesign Precision Medicine Opm SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Oncodesign Precision Medicine Opm SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Oncodesign Precision Medicine Opm SA?

You can check the latest Shariah compliance status of Oncodesign Precision Medicine Opm SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Oncodesign Precision Medicine Opm SA ALOPM.PA

€0.45 €0.00 (0.44%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALOPM.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 25, 2025

Report Source: 2024 Annual Report

Analyst's Ratings for Oncodesign Precision Medicine Opm SA (ALOPM.PA)

Based on 9 analysts giving stock ratings to Oncodesign Precision Medicine Opm SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Oncodesign Precision Medicine Opm SA. Stock Analysis ALOPM.PA

France Health Care Nano Cap Report: 2024 Annual

Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. The company employs 13 full-time employees The company went IPO on 2022-10-05. The company aims at providing effective diagnostic and therapeutic solutions for resistant and metastatic cancers. The Company’s technologies from Oncodesign, are OncoSNIPER for the selection of therapeutic targets using artificial intelligence; Nanocyclix for the design and selection of macrocyclic small molecule kinase inhibitors and Theranostics for the design and selection of radiolabeled biological molecules for systemic radiotherapy. The company focuses on the research and development of therapeutic and diagnostic solutions in the clinical and preclinical areas of medical oncology.

Key Statistics of Oncodesign Precision Medicine Opm SA (ALOPM.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.45€0.46

Today's Open

€0.45

Volume

1730.00

P/E Ratio (TTM)

52 Week Range

€0.28€0.92

Market Cap

8.74M

Avg. Volume

13.84K

Dividend Yield

Financial Metrics & Statements of Oncodesign Precision Medicine Opm SA (ALOPM.PA)

FAQ's for Oncodesign Precision Medicine Opm SA (ALOPM.PA)

According to Musaffa’s Shariah screening methodology, Oncodesign Precision Medicine Opm SA (ALOPM.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.